Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase

Background: Vancomycin is a glycopeptide antibiotic that was extensively used for treatment of gram positive infections. Therapeutic drug monitoring (TDM) is recommended to optimize efficacy and safety of vancomycin. Data regarding TDM of vancomycin are scant in septic patients especially during aug...

Full description

Bibliographic Details
Main Authors: Omid Arasteh, Hossein Khalili, Mohammad Taghi Beigmohammadi, Alireza Abdollahi, Amirhooshang Mohammadpour, Mohammadreza Salehi
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2019-07-01
Series:Archives of Anesthesia and Critical Care
Subjects:
Online Access:https://aacc.tums.ac.ir/index.php/aacc/article/view/238
_version_ 1811281291289559040
author Omid Arasteh
Hossein Khalili
Mohammad Taghi Beigmohammadi
Alireza Abdollahi
Amirhooshang Mohammadpour
Mohammadreza Salehi
author_facet Omid Arasteh
Hossein Khalili
Mohammad Taghi Beigmohammadi
Alireza Abdollahi
Amirhooshang Mohammadpour
Mohammadreza Salehi
author_sort Omid Arasteh
collection DOAJ
description Background: Vancomycin is a glycopeptide antibiotic that was extensively used for treatment of gram positive infections. Therapeutic drug monitoring (TDM) is recommended to optimize efficacy and safety of vancomycin. Data regarding TDM of vancomycin are scant in septic patients especially during augmented renal clearance (ARC) phase. Methods: In this observational study, 39 patients with diagnosis of sepsis that were in ARC phase were evaluated. The breakpoint for serum trough level of vancomycin was considered as 15 mg/l. The patients were stratified in two groups based on the measured serum trough levels (< 15 mg/l versus ≥15 mg/l). Results: Clinical response and microbiological clearance were compared between the groups. In terms of clinical response, there was no significant difference between the groups (P = 0.677). Also, the microbiological clearance was not different between the groups (P= 1.00). Conclusion: Septic patients during ARC phase had comparable clinical and microbial responses regardless of serum trough levels of vancomycin.
first_indexed 2024-04-13T01:30:53Z
format Article
id doaj.art-72694982f3954c98a6117d5806065774
institution Directory Open Access Journal
issn 2423-5849
language English
last_indexed 2024-04-13T01:30:53Z
publishDate 2019-07-01
publisher Tehran University of Medical Sciences
record_format Article
series Archives of Anesthesia and Critical Care
spelling doaj.art-72694982f3954c98a6117d58060657742022-12-22T03:08:31ZengTehran University of Medical SciencesArchives of Anesthesia and Critical Care2423-58492019-07-015310.18502/aacc.v5i3.1203Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance PhaseOmid Arasteh0Hossein Khalili1Mohammad Taghi Beigmohammadi2Alireza Abdollahi3Amirhooshang Mohammadpour4Mohammadreza Salehi5Department of Clinical Pharmacy, School of pharmacy, Tehran University of Medical Sciences, Tehran, Iran.Department of Clinical Pharmacy, School of pharmacy, Tehran University of Medical Sciences, Tehran, Iran.Department of Anesthesiology and Critical Care, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Department of Clinical Pharmacy, School of pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.Department of Infectious Diseases, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Background: Vancomycin is a glycopeptide antibiotic that was extensively used for treatment of gram positive infections. Therapeutic drug monitoring (TDM) is recommended to optimize efficacy and safety of vancomycin. Data regarding TDM of vancomycin are scant in septic patients especially during augmented renal clearance (ARC) phase. Methods: In this observational study, 39 patients with diagnosis of sepsis that were in ARC phase were evaluated. The breakpoint for serum trough level of vancomycin was considered as 15 mg/l. The patients were stratified in two groups based on the measured serum trough levels (< 15 mg/l versus ≥15 mg/l). Results: Clinical response and microbiological clearance were compared between the groups. In terms of clinical response, there was no significant difference between the groups (P = 0.677). Also, the microbiological clearance was not different between the groups (P= 1.00). Conclusion: Septic patients during ARC phase had comparable clinical and microbial responses regardless of serum trough levels of vancomycin.https://aacc.tums.ac.ir/index.php/aacc/article/view/238VancomycinClinical responseMicrobiological clearanceSepsis
spellingShingle Omid Arasteh
Hossein Khalili
Mohammad Taghi Beigmohammadi
Alireza Abdollahi
Amirhooshang Mohammadpour
Mohammadreza Salehi
Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
Archives of Anesthesia and Critical Care
Vancomycin
Clinical response
Microbiological clearance
Sepsis
title Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
title_full Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
title_fullStr Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
title_full_unstemmed Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
title_short Correlation between Serum Vancomycin Trough Level and Therapeutic Response in Septic Patients during Augmented Renal Clearance Phase
title_sort correlation between serum vancomycin trough level and therapeutic response in septic patients during augmented renal clearance phase
topic Vancomycin
Clinical response
Microbiological clearance
Sepsis
url https://aacc.tums.ac.ir/index.php/aacc/article/view/238
work_keys_str_mv AT omidarasteh correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase
AT hosseinkhalili correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase
AT mohammadtaghibeigmohammadi correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase
AT alirezaabdollahi correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase
AT amirhooshangmohammadpour correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase
AT mohammadrezasalehi correlationbetweenserumvancomycintroughlevelandtherapeuticresponseinsepticpatientsduringaugmentedrenalclearancephase